Aberrant O
perfusion O
and O
its O
connectivity O
within O
default O
mode O
network O
of O
first-episode O
drug-naïve O
schizophrenia O
patients O
and O
their O
unaffected O
first-degree O
relatives O
Neural O
substrates O
behind O
schizophrenia O
( O
SZ O
) O
and O
its O
heritability O
mediated O
by O
brain O
function O
are O
largely O
unknown O
. O

Cerebral O
blood O
flow O
( O
CBF O
) O
, O
as O
a O
biomarker O
of O
activation O
in O
the O
brain O
, O
reflects O
the O
neuronal O
metabolism O
, O
and O
is O
promisingly O
used O
to O
detect O
cerebral O
alteration O
thereby O
shedding O
light O
on O
the O
features O
of O
individuals O
at O
high O
genetic O
risk O
. O

We O
performed O
a O
cross-sectional O
functional O
magnetic O
resonance O
imaging O
( O
MRI O
) O
study O
enrolling O
45 O
first-episode O
drug-naïve O
patients O
with O
SZ O
, O
32 O
unaffected O
first-degree O
relatives O
of O
these O
patients O
, O
and O
51 O
healthy O
controls O
( O
HCs O
) O
. O

We O
examined O
CBF O
, O
CBF O
connectivity O
, O
and O
CBF O
topological O
properties O
. O

SZ O
patients O
showed O
increased O
CBF O
in O
the O
left O
medial O
superior O
frontal O
gyrus O
and O
right O
precuneus O
compared O
with O
HCs O
, O
and O
decreased O
CBF O
in O
the O
left O
middle O
temporal O
gyrus O
compared O
with O
their O
relatives O
. O

Furthermore O
, O
unaffected O
relatives O
revealed O
higher O
level O
of O
CBF O
pronounced O
in O
regions O
within O
default O
mode O
network O
( O
DMN O
) O
. O

Both O
SZ O
patients O
and O
their O
relatives O
exhibited O
dysconnectivity O
patterns O
. O

Notably O
, O
as O
for O
the O
network O
properties O
, O
unaffected O
relatives O
were O
with O
an O
intermediate O
level O
between O
SZ O
patients O
and O
HCs O
in O
the O
local O
efficiency O
and O
global O
efficiency O
. O

Our O
findings O
demonstrate O
the O
aberrant O
CBF O
of O
areas O
within O
DMN O
and O
the O
CBF O
connectivity O
pattern O
might O
be O
a O
familial O
feature O
in O
the O
brain O
of O
first-episode O
SZ O
patients O
and O
their O
relatives O
. O

Methods O
Participants O
This O
study O
was O
approved O
by O
the O
ethical O
committee O
of O
Xijing O
Hospital O
, O
and O
all O
participants O
provided O
written O
informed O
consent O
after O
complete O
description O
of O
the O
study O
. O

All O
experiments O
were O
performed O
in O
accordance O
with O
relevant O
guidelines O
and O
regulations O
. O

A O
total O
of O
demographically O
matched O
51 O
first-episode O
drug-naïve O
SZ O
patients O
, O
33 O
unaffected O
first-degree O
relatives O
of O
these O
SZ O
patients O
, O
and O
53 O
HCs O
were O
included O
in O
the O
experiment O
. O

In O
the O
subsequent O
analysis O
, O
six O
patients O
, O
one O
relative O
, O
and O
two O
HCs O
with O
excessive O
head O
motion O
( O
> O
3 O
mm O
translation O
and/or O
> O
3.0° O
rotation O
) O
were O
detected O
and O
then O
excluded O
from O
the O
current O
study O
. O

Subjects O
from O
our O
inpatient O
department O
or O
outpatient O
clinic O
were O
assessed O
according O
to O
the O
Diagnostic O
and O
Statistical O
Manual O
of O
Mental O
Disorders O
, O
Fourth O
Edition O
, O
Text O
Revision O
( O
DSM-IV-TR O
) O
criteria O
and O
consensus O
diagnoses O
of O
SZ O
were O
made O
using O
all O
the O
available O
information O
. O

This O
was O
based O
on O
the O
scores O
of O
the O
Positive O
And O
Negative O
Syndrome O
Scale O
( O
PANSS O
) O
( O
score O
≥ O
60 O
) O
at O
the O
time O
of O
scanning O
. O

The O
following O
exclusion O
criteria O
applied O
to O
all O
groups O
: O
history O
of O
significant O
neurological O
or O
systematic O
illness O
, O
diagnosis O
of O
substance O
abuse O
in O
the O
prior O
30 O
days O
or O
substance O
dependence O
in O
the O
prior O
6 O
months O
, O
another O
axis O
I O
or O
II O
psychiatric O
disorder O
, O
receiving O
antipsychotics O
and/or O
intervention O
using O
transcranial O
direct O
current O
stimulation O
, O
transcranial O
magnetic O
stimulation O
, O
electroconvulsive O
therapy O
or O
behavioral O
therapy O
, O
and O
pregnancy O
or O
MRI O
contraindications O
. O

The O
Prodromal O
Questionnaire O
was O
used O
to O
confirm O
the O
absence O
of O
any O
psychotic O
syndromes O
in O
relatives O
and O
HCs O
. O

Image O
acquisition O
As O
described O
previously O
, O
scanning O
was O
performed O
on O
a O
Siemens O
( O
Erlangen O
, O
Germany O
) O
3.0 O
T O
Trio O
MR O
scanner O
using O
the O
body O
coil O
for O
transmission O
and O
an O
eight O
channel O
head O
coil O
for O
reception O
. O

A O
10-min O
magnetization-prepared O
, O
rapid O
acquisition O
gradient O
echo O
( O
MPRAGE O
: O
192 O
slices O
, O
voxel O
size O
= O
1 O
× O
1 O
× O
1 O
mm3 O
, O
matrix O
= O
256 O
× O
256 O
, O
slice O
thickness O
= O
1 O
mm O
, O
gap O
= O
0 O
mm O
, O
FOV O
= O
256 O
× O
256 O
, O
repetition O
time O
= O
2530 O
ms O
, O
echo O
time O
= O
3.5 O
ms O
) O
image O
was O
first O
acquired O
. O

The O
resting-state O
perfusion O
imaging O
was O
performed O
using O
a O
pASL O
sequence O
( O
repetition O
time O
= O
2805 O
ms O
, O
echo O
time O
= O
13 O
ms O
, O
post-label O
delay O
= O
1800 O
ms O
, O
flip O
angle O
= O
90° O
; O
field O
of O
view O
= O
256 O
mm O
× O
256 O
mm O
; O
reconstruction O
matrix O
= O
256 O
× O
256 O
; O
slice O
thickness O
= O
3 O
mm O
, O
gap O
= O
0.75 O
mm O
; O
31 O
axial O
slices O
) O
. O

The O
acquisition O
time O
was O
4 O
min O
and O
20 O
s O
for O
the O
resting O
state O
ASL O
scan O
. O

During O
the O
ASL O
scan O
, O
all O
subjects O
were O
instructed O
to O
keep O
their O
eyes O
closed O
, O
relax O
and O
move O
as O
little O
as O
possible O
, O
think O
of O
nothing O
in O
particular O
, O
and O
not O
fall O
asleep O
. O

In O
order O
to O
avoid O
excessive O
head O
motion O
, O
we O
used O
a O
custom-built O
head O
cushion O
, O
reducing O
motion O
artifacts O
during O
acquisition O
. O

Thereafter O
, O
subjects O
with O
excessive O
head O
motion O
( O
> O
3 O
mm O
translation O
and/or O
3.0° O
rotation O
during O
scanning O
, O
as O
mentioned O
above O
) O
were O
excluded O
from O
the O
current O
study O
in O
order O
to O
control O
its O
potential O
confound O
effect O
. O

Additionally O
, O
we O
carefully O
checked O
images O
of O
each O
subject O
before O
further O
analysis O
, O
thereby O
ensuring O
the O
quality O
of O
data O
. O

CBF O
calculation O
As O
we O
performed O
recently O
, O
data O
analysis O
was O
implemented O
in O
Arterial O
Spin O
Labeling O
Perfusion O
MRI O
Signal O
Processing O
Toolbox O
( O
ASLtbx O
; O
http O
: O
//cfn.upenn.edu/~wangze/ASLtbx.php O
) O
in O
accordance O
with O
reports O
by O
Wang O
et O
al O
.. O

The O
detailed O
procedures O
, O
partly O
based O
on O
SPM12 O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm/ O
) O
, O
included O
image O
reorientation O
, O
motion O
correction O
, O
coregistering O
to O
each O
subject O
’ O
s O
anatomical O
image O
then O
to O
PET-perfusion O
templates O
and O
finally O
to O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
space O
by O
means O
of O
Affine O
transformation O
, O
spatial O
smoothing O
using O
a O
6 O
mm O
full-width O
at O
half-maximum O
( O
FWHM O
) O
Gaussian O
kernel O
, O
removing O
non-brain O
tissue O
, O
as O
well O
as O
CBF O
quantification O
. O

CBF O
connectivity O
analysis O
CBF O
matrix O
computation O
, O
connectivity O
matrix O
construction O
, O
and O
graph O
analysis O
were O
performed O
in O
the O
experiment O
using O
the O
method O
by O
Melie-Garcia O
et O
al. O
, O
in O
which O
a O
full O
description O
of O
this O
approach O
is O
available O
. O

First O
, O
parcellation O
, O
with O
90 O
anatomical O
structures O
using O
the O
automated O
anatomical O
labeling O
( O
AAL O
) O
atlas O
, O
was O
conducted O
to O
the O
preceding O
preprocessed O
CBF O
images O
for O
all O
the O
participants O
, O
yielding O
a O
matrix O
with O
“ O
n O
” O
( O
number O
of O
participants O
) O
rows O
by O
90 O
columns O
. O

Second O
, O
we O
defined O
a O
connection O
as O
statistical O
associations O
in O
CBF O
between O
brain O
regions O
for O
a O
particular O
parcellation O
and O
then O
constructed O
CBF O
connectivity O
matrix O
. O

We O
also O
calculated O
the O
sparsity/density O
of O
these O
matrices O
. O

The O
sparsity O
or O
density O
of O
a O
network O
is O
a O
fraction O
of O
the O
number O
of O
edges O
to O
the O
possible O
number O
of O
edges O
when O
the O
network O
is O
fully O
connected O
. O

Finally O
, O
we O
estimated O
global O
network O
properties O
, O
including O
clustering O
index O
, O
characteristic O
path O
length O
, O
and O
local O
and O
global O
efficiencies O
, O
to O
characterize O
brain O
CBF O
network O
. O

Statistical O
analysis O
The O
group O
differences O
in O
CBF O
were O
compared O
in O
a O
voxel-wise O
manner O
using O
a O
one-way O
analysis O
of O
variance O
( O
ANOVA O
) O
and O
two-sample O
t-test O
. O

Multiple O
comparisons O
were O
corrected O
using O
an O
AlphaSim O
correction O
with O
a O
threshold O
of O
P O
< O
0.005 O
( O
cluster O
> O
27 O
) O
according O
to O
the O
Correction O
Thresholds O
by O
AlphaSim O
module O
of O
Resting-State O
fMRI O
Data O
Analysis O
Toolkit O
V1.8 O
( O
http O
: O
//www.restfmri.net/forum/REST_V1.8 O
) O
. O

For O
two-sample O
t-tests O
, O
we O
used O
a O
higher O
level O
of O
threshold O
, O
i.e. O
, O
P O
< O
0.005/3 O
( O
AlphaSim O
correction O
, O
cluster O
> O
27 O
) O
, O
due O
to O
comparisons O
for O
three O
times O
. O

For O
each O
subject O
, O
Pearson O
correlation O
coefficients O
between O
brain O
function O
measures O
of O
each O
cluster O
with O
a O
significant O
group O
difference O
and O
the O
severity O
of O
symptoms O
( O
PANSS O
scores O
) O
were O
separately O
computed O
for O
SZ O
patient O
group O
. O

Correlation O
analyses O
were O
performed O
with O
SPSS O
software O
( O
version O
13.0 O
, O
SPSS O
, O
Inc. O
) O
. O

Significance O
was O
set O
at O
P O
< O
0.05 O
. O

For O
CBF O
connectivity O
, O
Fisher O
’ O
s O
z O
test O
was O
then O
used O
to O
compare O
correlations O
between O
two O
groups O
( O
http O
: O
//www.fon.hum.uva.nl/Service/Statistics/Two_Correlations.html O
) O
. O

